Grupo Televisa: Q2 Earnings Snapshot
The Mexico City-based company said it had net income of 5 cents per share.
The media company posted revenue of $755.7 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TV at https://www.zacks.com/ap/TV
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here's what investors should know. Hologic met analysts' revenue expectations last quarter, reporting revenues of $1.01 billion, down 1.2% year on year. It was a slower quarter for the company, with a slight miss of analysts' full-year EPS guidance estimates and full-year revenue guidance meeting analysts' expectations. Is Hologic a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Hologic's revenue to be flat year on year at $1.01 billion, slowing from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.05 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hologic has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.9% on average. Looking at Hologic's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Hologic is up 2.8% during the same time and is heading into earnings with an average analyst price target of $69.93 (compared to the current share price of $66.99). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
‘The Naked Gun': First Reactions From the Premiere
It's been a 31-year wait, but the latest addition to The Naked Gun franchise is finally here. Full critics' reviews for the film drop on Wednesday, but fans of the classic spoof comedy franchise can breathe a huge sigh of relief, as the early social media reaction from Monday's New York premiere and press screenings is extremely effusive. The new iteration of The Naked Gun, stars Liam Neeson as Lt. Frank Drebin Jr., the son of Police Squad legend Frank Drebin, played in the franchise's previous projects by the late Leslie Nielsen. Pamela Anderson, Paul Walter Hauser, Kevin Durand, Danny Huston, Liza Koshy, Cody Runnels and CCH Pounder round out the cast. More from The Hollywood Reporter Stormtrooper Helmet From 'Star Wars: A New Hope' Sells for $256K at Auction Hollywood Flashback: Before 'The Naked Gun,' 'Police Squad!' Took Its Shot Wolf Kasteler Public Relations Promotes Allie Jenkins and Chelsea Hayes to Senior VP The Lonely Island's Akiva Schaffer directs the reboot and Seth MacFarlane produces a project that Paramount has had in the works for decades. The film franchise is based on the 1982 ABC television series Police Squad!, a spoof on police procedural dramas that introduced Nielsen as Drebin and was co-created and written by David Zucker, Jim Abrahams and Jerry Zucker. Though the TV show was short-lived, the creative team reunited for the first feature in the franchise, 1988's The Naked Gun: From the Files of Police Squad!. Two more sequels were released: The Naked Gun 2½: The Smell of Fear in 1991 and Naked Gun 33⅓: The Final Insult in 1994. The Naked Gun will be released in theaters worldwide on Aug. 1. Before the film's release, and full critics' reviews, read on for a sampling of early reaction from Monday's premiere and press screenings. Best of The Hollywood Reporter The 40 Greatest Needle Drops in Film History The 40 Best Films About the Immigrant Experience Wes Anderson's Movies Ranked From Worst to Best Solve the daily Crossword
Yahoo
23 minutes ago
- Yahoo
CONMED (CNMD) Q2 Earnings: What To Expect
Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here's what to look for. CONMED beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $321.3 million, up 2.9% year on year. It was a very strong quarter for the company, with a solid beat of analysts' full-year EPS guidance estimates and an impressive beat of analysts' EPS estimates. Is CONMED a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting CONMED's revenue to grow 1.9% year on year to $338.3 million, slowing from the 4.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CONMED has missed Wall Street's revenue estimates three times over the last two years. Looking at CONMED's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. CONMED is down 4% during the same time and is heading into earnings with an average analyst price target of $66.60 (compared to the current share price of $50.02). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
